echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Adv. Sci.: A built-in aptamer reservoir with nuclease-resistant 3D cascade assembled DNA nanoclusters for precision cancer treatment

    Adv. Sci.: A built-in aptamer reservoir with nuclease-resistant 3D cascade assembled DNA nanoclusters for precision cancer treatment

    • Last Update: 2022-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Innovation: Wu Regener's team at Fuzhou University has developed aptamer embedded 3D DNA nanoclusters (Apt-eNC) as intelligent carriers
    for cancer targeted drug delivery.
    Apt-eNC is designed to have a built-in reserve pool in the inner cavity where the aptamer can move
    outward.
    When surface aptamers are degraded, the aptamers in the reserve pool can move outward to provide compensation, thereby maintaining their continuous tumor-targeting performance in vivo, providing new ideas
    for precision cancer treatment.

    Keywords: 3D layered DNA nanoclusters, built-in aptamer reservoir, cancer precision treatment, outward movement

    Chemotherapy drugs have been widely used in the treatment
    of various cancers as the main anti-cancer drugs.
    However, standard chemotherapy drugs lack tumor targeting capabilities and are often distributed non-specifically throughout the body through the systemic circulation, inevitably leading to severe damage
    to healthy tissues and organs.
    In order to alleviate systemic toxicity, traditional anti-cancer drugs need to reduce the dose of the drug to a level lower than normal cells can tolerate, without side effects on normal cells, directly leading to insufficient dose in the tumor area, thereby affecting its inherent therapeutic effect
    .
    Therefore, there is an urgent need to develop a specific tumor-targeted drug delivery system
    for cancer chemotherapy.
    As a natural biological macromolecule, DNA has the characteristics of high water solubility, good biocompatibility, modifiability and drug loading, and is a potential raw material for the construction of DNA drug carriers.
    Functional nucleic acids (aptamers) have cell-targeting capabilities comparable to antibodies, but they are easily degraded
    .
    Although chemical modification can enhance the stability of aptamers, chemical modifications often weaken or lose aptamer recognition, and bring additional toxic side effects
    .
    Safety hazards and insufficient efficacy of chemotherapy have become the two main limitations of
    DNA nanostructured drug carriers failing in clinical trials.
    Considering that rigid and dense DNA nanostructures have strong resistance to nuclease degradation, can prolong blood circulation time, and have enough time to search for and gather at cancerous sites, it is urgent and urgent to develop a multifunctional drug delivery vector with high biocompatibility, high drug load, good anti-degradation ability, and can prevent accidental drug leakage and enhance tumor accumulation in vivo
    .

    The Wu Regeng team of Fuzhou University discussed the above problems: a 3D DNA nanocluster structure (Apt-eNC) embedded by aptamers was constructed as an intelligent carrier for cancer targeted drug delivery, and Apt-eNC composites loaded with anti-cancer drugs were used to achieve precise treatment
    of cancer.
    The results were published in
    Advanced Science.

    Based on unique structural features, Apt-eNC has shown obvious advantages
    in targeted drug delivery.
    (a) Long
    circulation time in the body.
    sgc8-eNC can maintain its structural integrity in serum solution or in vivo environment for 8 hours
    .
    (b) Extremely high cargo loading capacity
    .
    Sgc8-eNC consists of 283 Tetra units with enough binding sites to accommodate a large number of therapeutic agents, making the drug-to-carrier ratio as high as 5670:1, and the drug-loaded material can remain stable under physiological pH to prevent early leakage
    .
    (c) Sustained tumor targeting in a complex environment
    .
    Drug-loaded Apt-eNC can specifically identify PTK7-positive tumor cells and specifically internalize into tumor tissues
    through receptor-guided endocytosis.
    In addition, it can maintain the targeted activity of tumor tissue during blood circulation, reducing off-target toxic side effects
    that are harmful to healthy tissues of the delivered drug.
    (d) Good biocompatibility
    .
    Even with very high concentrations of DNA components, Apt-eNC is not significantly toxic
    at the cellular level.
    After intensive loading of chemotherapy drugs, there were no significant cytotoxicity or adverse reactions
    to healthy tissues and normal organs at the systemic level.
    (e) Good versatility
    due to significant sequence programmability.
    (f) The material construction procedure is simple and the assembly efficiency is high
    .
    It is worth noting that the experimental data from nuclease degradation resistance, payload capacity and molecular mechanisms of targeting tumors in vivo, especially the therapeutic effect of targeted delivery of drugs to tumor tissues and tumor tissues through in vivo circulation, show that Apt-eNC is a drug delivery system
    with precise targeting capabilities 。 More importantly, the specific birigid structure and the ingenious design of the built-in aptamer reserve pool provide important new technical references for the design of complex DNA structures, such as the anti-degradation ability of nucleases with enhanced mechanical stiffness and the spatial displacement effect of automatically adjusting recognition elements, which provides new ideas
    for maintaining the targeted activity of drug carriers, sufficient delivery, and finally meeting the requirements of professional applications in the biomedical field.


    WILEY


    Paper Information:

    Outward Movement of Targeting Ligands from a Built-In Reserve Pool in Nuclease-Resistant 3D Hierarchical DNA Nanocluster for in Vivo High-Precision Cancer Therapy

    Weijun Wang, Yansha Gao, Yaxin Chen, Wenqing Wang, Qian Li, Zhiyi Huang, Jingjing Zhang, Qi Xiang, and Zai-Sheng Wu

    Advanced Science

    DOI: 10.
    1002/advs.
    202203698

    Click "Read Original" in the lower left corner to view the original paper
    .

    Advanced

    Science

    Introduction to the journal

    Advanced Science is a high-quality open source journal founded by Wiley in 2014, publishing innovative achievements and cutting-edge progress
    in various fields such as materials science, physical chemistry, biomedicine, and engineering.
    In an effort to maximize the dissemination of scientific research to the public, all articles are freely available
    .
    Included in Medline, available on PubMed
    .
    The latest impact factor is 17.
    521, and the 2021 SCI journal of the Chinese Academy of Sciences is divided into Q1 area of material science category and Q1 area
    of engineering technology category.





    AdvancedScienceNews

    Wiley's official WeChat platform for scientific research information

    Long press the QR code to follow us

    Share cutting-edge information | focus on scientific research trends

    To publish research news or apply for information sharing, please contact: ASNChina@Wiley.
    com


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.